BlackRock Advisors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$933K Buy
12,841
+633
+5% +$54.2K ﹤0.01% 1890
2016
Q3
$1.27M Buy
12,208
+2,286
+23% +$206K ﹤0.01% 1692
2016
Q2
$732K Buy
9,922
+2,580
+35% +$175K ﹤0.01% 1911
2016
Q1
$413K Buy
7,342
+490
+7% +$28.9K ﹤0.01% 2180
2015
Q4
$463K Sell
6,852
-3,443
-33% -$184K ﹤0.01% 2111
2015
Q3
$478K Buy
10,295
+1,479
+17% +$71.7K ﹤0.01% 2222
2015
Q2
$474K Sell
8,816
-27,084
-75% -$1.38M ﹤0.01% 2216
2015
Q1
$1.72M Sell
35,900
-80,557
-69% -$3.5M ﹤0.01% 1284
2014
Q4
$4.5M Buy
+116,457
New +$3.67M ﹤0.01% 989

Other funds holding NVRO

BlackRock Advisors's NVRO Position: Q4 2016 in Review

BlackRock Advisors increased its NEVRO CORP. (NVRO) stake by 5.2% in Q4 2016, buying an estimated $54.2K and bringing the position to 12,841 shares worth $933K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

BlackRock Advisors first reported a position in NVRO in Q4 2014 and has held it in 9 quarters since. The position peaked at $4.5M in Q4 2014. 174 funds tracked by Wall St. Rank hold NVRO as of Q4 2016.

  • BlackRock Advisors held 12,841 shares of NEVRO CORP. worth $933K as of Q4 2016.
  • BlackRock Advisors bought 633 NEVRO CORP. shares in Q4 2016, an estimated $54.2K.
  • NEVRO CORP. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1890 holding.
  • BlackRock Advisors first reported a position in NEVRO CORP. in Q4 2014 and has held it in 9 quarters since.
  • BlackRock Advisors's NEVRO CORP. position peaked at $4.5M in Q4 2014.
  • 174 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.